For research use only. Not for therapeutic Use.
MIM1 (Cat.No:I003814) is a small molecule inhibitor that targets the MALT1 protein, an important regulator of NF-κB signaling pathway. By binding to MALT1, MIM1 disrupts its protease activity, inhibiting downstream signaling events involved in immune response and inflammation. MIM1 is being studied for its potential therapeutic applications in various immune-related disorders and cancers.
| Catalog Number | I003814 |
| CAS Number | 509102-00-5 |
| Synonyms | 4-((E)-(((Z)-2-(cyclohexylimino)-4-methylthiazol-3(2H)-yl)imino)methyl)benzene-1,2,3-triol |
| Molecular Formula | C17H21N3O3S |
| Purity | ≥95% |
| Target | Bcl-2 Family |
| Solubility | 10 mM in DMSO |
| Storage | Store at 4°C |
| IC50 | 4.8 uM |
| InChIKey | RGGFUBMUOVFZEF-LDRVEFRDSA-N |
| Reference | <p style=/line-height:25px/> </p> |
